Aegis Capital Starts Akers Biosciences (AKER) at Buy
Tweet
Share
E-mailGet Alerts AKER Hot Sheet
Price: $2.47 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Aegis Capital initiated coverage on Akers Biosciences (NASDAQ: AKER) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Akers Biosciences click here. For more ratings news on Akers Biosciences click here.
Shares of Akers Biosciences closed at $4.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
- Jefferies Starts Aehr Test Systems (AEHR) at Buy
- Lake Street Starts RF Industries Ltd. (RFIL) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
